Improved strut coverage and less late incomplete apposition with thin-strut TAXUS Liberté vs. TAXUS Express: The importance of stent platform design for drug-eluting stents

Cardiovascular Revascularization Medicine

Volumn 12, Issue 4, 2011, Pages 247-257

  Weissman, Neil J ^a   Turco, Mark A ^b   Ormiston, John A ^c   Mann, Tift ^d   Cannon, Louis A ^e   McGarry, Thomas F ^f   Webster, Mark W I ^g   Hall, Jack J ^h   Lucca, Michael J ⁱ   Mishkel, Gregory J ^j   Wu, Chiung Jen ^k   Mandinov, Lazar ^l   Dawkins, Keith D ^l  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b WASHINGTON ADVENTIST HOSPITAL   (United States)

^c Mercy Hospital   (New Zealand)

^d WAKEMED HEALTH AND HOSPITALS   (United States)

^e Northern Michigan Regional Health Systems   (United States)

^f Oklahoma Heart Hospital   (United States)

^g AUCKLAND CITY HOSPITAL   (New Zealand)

^h ST VINCENT HOSPITAL   (United States)

ⁱ Duluth Clinic   (United States)

^j ST JOHN'S HOSPITAL   (United States)

^k CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^l BOSTON SCIENTIFIC CORPORATION   (United States)

more..

Author keywords

Intravascular ultrasound; Paclitaxel; Restenosis; Stent

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; PACLITAXEL; POLYSTYRENE DERIVATIVE; TICLOPIDINE;

ADULT; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ELUTING STENT; EQUIPMENT DESIGN; FEMALE; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); NEOINTIMA; PRIORITY JOURNAL; RANDOMIZATION; SLOW RELEASE FORMULATION;

CARDIOVASCULAR AGENTS; CORONARY RESTENOSIS; CORONARY STENOSIS; CORONARY VESSELS; DOUBLE-BLIND METHOD; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; STENTS; TREATMENT OUTCOME; TUNICA INTIMA; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 79960701401     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2010.09.008     Document Type: Article

References (12)

1. Ahmed W Review of the TAXUS Liberté SR paclitaxel-eluting coronary stent. Expert Rev Med Devices 2007, 4(2):117-120.
2. Turco MA, Ormiston JA, Popma JJ, Mandinov L, O'Shaughnessy CD, Mann T, McGarry TF, Wu C-J, Chan C, Webster MWI, Hall JJ, Mishkel GJ, Cannon LA, Baim DS, Koglin J Polymer-based, paclitaxel-eluting TAXUS Liberte stent in de novo lesions: The Pivotal TAXUS ATLAS Trial. J Am Coll Cardiol 2007, 49(16):1676-1683.
3. Turco MA, Ormiston JA, Popma JJ, Hall JJ, Mann T, Cannon LA, Webster MWI, Mishkel GJ, O'Shaughnessy CD, McGarry TF, Mandinov L, Dawkins KD, Baim DS Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-Strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS Program. J Am Coll Cardiol Intv 2008, 1(6):699-709.
4. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004, 350(3):221-231.
5. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O'Shaughnessy CD, DeMaio S, Hall P, Popma JJ, Koglin J, Russell ME Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 2005, 294(10):1215-1223.
6. Simon C, Palmaz JC, Sprague EA Influence of topography on endothelialization of stents: clues for new designs. J Long Term Eff Med Implants 2000, 10(1-2):143-151.
7. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006, 48(1):193-202.
8. Farb A, Burke AP, Kolodgie FD, Virmani R Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003, 108(14):1701-1706.
9. Ako J, Morino Y, Honda Y, Hassan A, Sonoda S, Yock PG, Leon MB, Moses JW, Bonneau HN, Fitzgerald PJ Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coll Cardiol 2005, 46(6):1002-1005.
10. Weissman NJ, Ellis SG, Grube E, Dawkins KD, Greenberg JD, Mann T, Cannon LA, Cambier PA, Fernandez S, Mintz GS, Mandinov L, Koglin J, Stone GW Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials. Eur Heart J 2007, 28(13):1574-1582.
11. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, Vogel R, Hess O, Meier B, Windecker S Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007, 115(18):2426-2434.
12. Kimura M, Mintz GS, Carlier S, Takebayashi H, Fujii K, Sano K, Yasuda T, Costa RA, Costa JJR, Quen J, Tanaka K, Lui J, Weisz G, Moussa I, Dangas G, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound. Am J Cardiol 2006, 98(4):436-442.